EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 Diabetes

Wei Liu, Deheng Cai iD, Rui Zhang, Xiuying Zhang, Xiaoling Cai, Liyuan Tao, Xueyao Han, Yingying Luo, Meng Li, Wenjing Wu, Yumin Ma, Dawei Shi iD und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae143 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Wei Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, PR China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Blood Glucose, Hypoglycemic Agents, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: This work was supported by the National Key Research and Development Program of China, Peking University People's Hospital Scientific Research Development Funds, Peking University Medical Science and Technology Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

We propose an artificial-pancreas-like algorithm (AP-A) that could automatically determine the preprandial insulin dose based on intermittently scanned continuous glucose monitoring (isCGM) data trajectories in multiple dose injection (MDI) therapy.

Objective

We aim to determine whether preprandial insulin dose adjustments guided by the AP-A are as effective and safe as physician decisions.

Methods

We performed a randomized, single-blind, clinical trial at a tertiary, referral hospital in Beijing, China. Type 2 diabetes participants were eligible if they were aged 18 years or older, with a glycated hemoglobin A1c of 8.0% or higher. Eligible participants were randomly assigned (1:1) to the AP-A arm supervised by physician and the conventional physician treatment arm. The primary objective was to compare percentage time spent with sensor glucose level in 3.9 to 10.0 mmol/L (TIR) between the 2 study arms. Safety was assessed by the percentage time spent with sensor glucose level below 3.0 mmol/L (TBR).

Results

A total of 140 participants were screened, of whom 119 were randomly assigned to the AP-A arm (n = 59) or physician arm (n = 60). The TIR achieved by the AP-A arm was statistically noninferior compared with the control arm (72.4% [63.3%-82.1%] vs 71.2% [54.9%-81.4%]), with a median difference of 1.33% (95% CI, −6.00 to 10.94, noninferiority margin −7.5%). TBR was also statistically noninferior between the AP-A and control arms (0.0% [0.0%-0.0%] vs 0.0% [0.0%-0.0%]), respectively; median difference (95% CI, 0.00% [0.00%-0.00%], noninferiority margin 2.0%).

Conclusion

The AP-A–supported physician titration of preprandial insulin dosage offers noninferior glycemic control compared with optimal physician care in type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Blood GlucoseHypoglycemic AgentsBlood Glucose Self-MonitoringInsulinGlycated HemoglobinHumansMiddle AgedMaleFemaleSingle-Blind MethodAgedAdultMealsAlgorithmsPancreas, ArtificialGlycemic Control

Stichwörter der Autor:innen

artificial pancreasglucose controlinsulin treatmentmultiple daily injectionstype 2 diabetes

Substanzen

Blood GlucoseHypoglycemic AgentsInsulinGlycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, PR China.
  • School of Automation, Beijing Institute of Technology, Beijing 100081, PR China.
  • Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100083, PR China.
  • Department of Endocrinology and Metabolism, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu 225000, PR China.

ORCID-Profile: Deheng Cai, Dawei Shi, Linong Ji

Förderung

  • This work was supported by the National Key Research and Development Program of China
  • Peking University People's Hospital Scientific Research Development Funds
  • Peking University Medical Science and Technology Fund
  • National Natural Science Foundation of China
  • Peking University People’s Hospital Scientific Research Development Funds

Zitieren

APA

Liu, W., Cai, D., Zhang, R., Zhang, X., Cai, X., Tao, L., Han, X., Luo, Y., Li, M., Wu, W., Ma, Y., Shi, D., & Ji, L. (2024). A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae143

Vancouver

Liu W, Cai D, Zhang R, Zhang X, Cai X, Tao L, et al. A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae143

BibTeX
@article{Liu2024,
  author = {Liu, Wei and Cai, Deheng and Zhang, Rui and Zhang, Xiuying and Cai, Xiaoling and Tao, Liyuan and Han, Xueyao and Luo, Yingying and Li, Meng and Wu, Wenjing and Ma, Yumin and Shi, Dawei and Ji, Linong},
  title = {A Randomized Clinical Trial for Meal Bolus Decision Using Learning-based Control in Adults With Type 2 Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae143}
}
Kostenlos starten →